Epistem licenses Hubrecht Organoid Technology Epistem Limited, a UK-based pre-clinical and clinical research services company, has expanded its in vitro model portfolio through an agreement with Hubrecht Organoid Technology (HUB). The... GI Toxicity, Oncology, Organoids 16-07-19
